IGC Pharma, Inc. (IGC)
NYSE: IGC · Pharmaceutical Preparations · Potomac, MD · filing with the SEC since 2005
Who runs IGC Pharma, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Mukunda Ram
CEO. First filing Mar 2006, latest Sep 29, 2026, 7 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
9 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mukunda Ram | CEO | Mar 2006 | Sep 29, 2026 | none |
| Grimaldi Claudia | PFO | Jul 2018 | Sep 29, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Moran James P | director | Jan 2022 | Apr 6, 2026 | none |
| Prins Richard K | director | May 2009 | Apr 6, 2026 | none |
| Lierman Terry L | director | Mar 2024 | Oct 21, 2025 | none |
Earlier names on the record5, newest filing first
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857) · 10% owner · last filing May 2024Lynch John Edward · director · last filing Jun 2022Goel Rohit · officer · last filing May 2021Shenoy Sudhakar V · director · last filing Jun 2019Cherin John · officer · last filing Sep 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.